BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12176808)

  • 1. Infliximab treatment in combination with cyclosporin A in patients with severe refractory rheumatoid arthritis.
    Temekonidis TI; Georgiadis AN; Alamanos Y; Bougias DV; Voulgari PV; Drosos AA
    Ann Rheum Dis; 2002 Sep; 61(9):822-5. PubMed ID: 12176808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent clinical response of infliximab therapy in patients with refractory rheumatoid arthritis, over a 3-year period.
    Voulgari PV; Alamanos Y; Drosos AA
    Curr Clin Pharmacol; 2006 Jan; 1(1):103-8. PubMed ID: 18666381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial.
    Fleischmann RM; Cohen SB; Moreland LW; Schiff M; Mease PJ; Smith DB; Keenan G; Kremer JM;
    Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab therapy in established rheumatoid arthritis: an observational study.
    Voulgari PV; Alamanos Y; Nikas SN; Bougias DV; Temekonidis TI; Drosos AA
    Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
    Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M
    Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.
    Ferraccioli GF; Assaloni R; Di Poi E; Gremese E; De Marchi G; Fabris M
    Rheumatology (Oxford); 2002 Oct; 41(10):1109-12. PubMed ID: 12364628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study.
    Durez P; Van den Bosch F; Corluy L; Veys EM; De Clerck L; Peretz A; Malaise M; Devogelaer JP; Vastesaeger N; Geldhof A; Westhovens R
    Rheumatology (Oxford); 2005 Apr; 44(4):465-8. PubMed ID: 15695306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study.
    Drosos AA; Voulgari PV; Papadopoulos IA; Politi EN; Georgiou PE; Zikou AK
    Clin Exp Rheumatol; 1998; 16(6):695-701. PubMed ID: 9844762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
    Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
    Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for the treatment of rheumatoid arthritis.
    Blumenauer B; Judd M; Wells G; Burls A; Cranney A; Hochberg M; Tugwell P
    Cochrane Database Syst Rev; 2002; 2002(3):CD003785. PubMed ID: 12137712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.
    St Clair EW; van der Heijde DM; Smolen JS; Maini RN; Bathon JM; Emery P; Keystone E; Schiff M; Kalden JR; Wang B; Dewoody K; Weiss R; Baker D;
    Arthritis Rheum; 2004 Nov; 50(11):3432-43. PubMed ID: 15529377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good response to infliximab in rheumatoid arthritis following failure of interleukin-1 receptor antagonist.
    Bao J; Yue T; Li T; He DY; Bao YX
    Int J Rheum Dis; 2016 Apr; 19(4):370-6. PubMed ID: 24798350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis.
    Westhovens R; Houssiau F; Joly J; Everitt DE; Zhu Y; Sisco D; Van Hartingsveldt B; Mascelli MA; Graham MA; Durez P; Bouman-Thio E
    J Rheumatol; 2006 May; 33(5):847-53. PubMed ID: 16583466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
    J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with infliximab.
    Argyropoulou MI; Glatzouni A; Voulgari PV; Xydis VG; Nikas SN; Efremidis SC; Drosos AA
    Joint Bone Spine; 2005 Dec; 72(6):557-61. PubMed ID: 16376805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.
    Gerards AH; Landewé RB; Prins AP; Bruyn GA; Goei Thé HS; Laan RF; Dijkmans BA
    Ann Rheum Dis; 2003 Apr; 62(4):291-6. PubMed ID: 12634224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis].
    Wiland P; Głowska A; Chlebicki A; Szechiński J
    Pol Arch Med Wewn; 2002 Nov; 108(5):1055-63. PubMed ID: 12685246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.